Almujtama Alraida Medical Co. Announces the Results of the Ordinary General Assembly Meeting (First Meeting)

Element List	Explanation
Introduction	Almujtama Alraida Medical Co. announces the results of the Ordinary General Assembly Meeting (First Meeting), which was held by means of modern technology at 8:30 PM on Monday, 14 Muharram 1448 AH, corresponding to June 29, 2026. The meeting was duly convened after the required quorum had been attained, in accordance with the Company's Articles of Association.
City and Location of the General Assembly's Meeting	The company's main headquarters is in Jeddah, Al-Muhammadiyah district, through modern technological means.
Date of the General Assembly's Meeting	2026-06-29 Corresponding to 1448-01-14
Time of the General Assembly’s Meeting	20:30
Percentage of Attending Shareholders	65.59 %
Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees	The following members of the Board of Directors attended the meeting: Mr. Omar Yousef Khojah (Chairman of the Board of Directors) Mr. Yousef Omar Khojah (Vice Chairman of the Board of Directors) Pharmacist/ Abdulaziz Omar Khojah (Member of the Board of Directors) Mr. Ahmed Abdel-Ilah Maghribi (Member of the Board of Directors) Mr. Karim Bachite (Member of the Board of Directors) Mr. Hamad Hamdan Al-Sourayia (Member of the Board of Directors)
Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf	The meeting was attended by the following committee heads: Mr. Awad Hamouda Al-Rubaie (Chairman of the Audit Committee) Mr. Ahmed Abdel-Ilah Maghribi (Chairman of the Nominations and Remuneration Committee)
Voting Results on the Items of the General Assembly's Meeting Agenda's	1. The Board of Directors' report for the financial year ended 31 December 2025 was reviewed and discussed. 2. The financial statements for the fiscal year ended 31 December 2025 were reviewed and discussed. 3. Approval of the Company’s auditor’s report for the fiscal year ending on December 31, 2025, following its discussion. 4. Approval of the payment of remuneration to the Board of Directors members in the amount of SAR 906,575 for the fiscal year ending on December 31, 2025. 5. Approval to discharge the members of the Board of Directors from liability for the fiscal year ending on December 31, 2025. 6. Approval of the appointment of Talal Abu-Ghazaleh & Co. (Certified Public Accountants) as the Company’s external auditor selected from among the candidates based on the Audit Committee’s recommendation for a fee of SAR 275,000 (excluding 15% VAT). The engagement entails examining, reviewing, and auditing the semi-annual and annual financial statements for the fiscal year ending December 31, 2026, and filing the Zakat declaration for the year 2026. 7. Approval of the Board of Directors' recommendation to distribute cash dividends totaling SAR 2,375,000 to shareholders for the fiscal year 2025, at a rate of SAR 0.25 per share representing 2.5% of the Company’s capital of SAR 95,000,000. Eligibility for dividends shall be for shareholders owning shares at the end of the trading day of the General Assembly meeting and registered in the Company’s shareholder register with the Securities Depository Center Company (Edaa) at the end of the second trading day following the date of the General Assembly meeting; dividend distribution shall commence on July 19, 2026. 8. Approval to authorize the Board of Directors to distribute interim dividends to shareholders on a semi-annual or quarterly basis for the fiscal year 2026, and to determine the payment and entitlement dates. 9. Approval of the transactions and contracts executed during 2025 between the Company and Mr. Omar Yousef Khojah. Mr. Omar Yousef Khojah (Chairman of the Board) has a direct interest in these contracts, while Mr. Yousef Omar Khojah (Vice Chairman) and Pharmacist Abdulaziz Omar Khojah (Board Member) have an indirect interest. The arrangement consists of a lease agreement for a branch in the Al-Shara'a district of Jeddah, with an annual value of SAR 160,000 (excluding 15% VAT) and a one-year term expiring on September 6, 2026. The value of transactions during the 2025 fiscal year amounted to SAR 160,000 (excluding 15% VAT), along with the request for approval to renew the contract for the year 2026 for a one-year term ending on September 6, 2027, it is confirmed that all contract terms have been agreed upon without granting any privileges or preferential conditions to either party. 10. Approval of the transactions and contracts concluded between the Company and Mr. Omar Yousef Khojah, in which the Chairman of the Board, Mr. Omar Yousef Khojah, holds a direct interest, while the Vice Chairman, Mr. Yousef Omar Khojah, and Board Member Pharmacist Abdulaziz Omar Khojah hold an indirect interest. These transactions consist of a lease agreement for a branch in the Al-Sanabil district of Jeddah for a period of (10) years, commencing on April 1, 2023, with a total rental value of SAR 5,500,000 (excluding 15% Value Added Tax); the value of transactions during the 2025 fiscal year amounted to SAR 550,000 (excluding 15% Value Added Tax), along with a request for authorization to extend the contract for the 2026 fiscal year. It should be noted that this contract was concluded without any preferential terms or benefits. 11. Approval of the transactions and contracts concluded between the Company and Mr. Omar Yousef Khojah in which the Chairman of the Board, Mr. Omar Yousef Khojah, holds a direct interest, while the Vice Chairman, Mr. Yousef Omar Khojah, and Board Member Pharmacist Abdulaziz Omar Khojah hold an indirect interest. These consist of a lease agreement for a branch in the Al-Ruhaili district of Jeddah for a term of 9 years and 11 months, commencing on May 1, 2023, with a total rental value of SAR 3,966,667 (excluding 15% VAT). The value of transactions during the 2025 fiscal year amounted to SAR 400,000 (excluding 15% VAT), along with a request for authorization to extend the contract for the 2026 fiscal year. It should be noted that this contract was concluded without any preferential terms or benefits. 12. Approval of the transactions and contracts concluded between the Company and Mr. Omar Yousef Khojah in which the Chairman of the Board, Mr. Omar Yousef Khojah, holds a direct interest, while the Vice Chairman, Mr. Yousef Omar Khojah, and Board Member Pharmacist Abdulaziz Omar Khojah hold an indirect interest. These consist of a lease agreement for a branch in the Al-Marwa district of Jeddah for a period of (10) years, commencing on July 1, 2024, with a total rental value of SAR 4,200,000 (excluding 15% VAT); the value of transactions during the 2025 fiscal year amounted to SAR 420,000 (excluding 15% VAT), along with a request for authorization to extend the contract for the 2026 fiscal year. It should be noted that this contract was concluded without any preferential terms or benefits. 13. Disapproval of the transactions and contracts concluded between the company and Bright Screens Co. (a single-person limited liability company owned by Mr. Mohammed Omar Khojah), in which the Chairman of the Board, Mr. Omar Yousef Khojah, the Vice Chairman of the Board, Mr. Yousef Omar Khojah, and Board Member, Pharmacist Abdul Aziz Omar Khojah, have an indirect interest. This interest is represented by a contract for the supply and installation of advertising screens with a total contract value of SAR 1,537,200, excluding VAT (15%). The value of transactions during the fiscal year 2025 amounted to SAR 699,478, excluding VAT (15%), along with a request for authorization to continue supply for the 2026 fiscal year, it should be noted that this contract was concluded without preferential terms or benefits.
Additional Information	With reference to Article 67 of the Implementing Regulations of the Companies Law concerning listed joint-stock companies, and regarding Item (13) which concerns business dealings and contracts between the Company and Bright Screens Co. in which the Chairman (Mr. Omar Yousef Khojah), the Vice Chairman (Mr. Yousef Omar Khojah), and Board Member (Pharmacist Abdulaziz Omar Khojah) hold an indirect interest, and which had not previously been approved by the General Assembly the General Assembly has granted the aforementioned members a period of six (6) months to take the necessary measures to rectify and resolve the situation in accordance with relevant laws and regulations.